SOR-C13 emerges as a paradigm-shifting therapeutic solution against multifarious cancer phenotypes. Employing an ingenious mechanism, this potent compound efficaciously obstructs the nefarious SORCIN protein, thereby orchestrating a comprehensive blockade on the pernicious proliferation and dissemination of malignant tumors. Exuding its benevolence, SOR-C13 illumines a path of sanguine expectations for those afflicted with lung, breast, prostate, and ovarian cancer, heralding a captivating era of tailor-made therapeutic interventions in the intricate realm of oncology.
CAT No: R2062
CAS No:1187852-48-7
Synonyms/Alias:SOR-C13;UNII-C79B5A73C4;1187852-48-7;C79B5A73C4;L-Arginine, L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-leucyl-L-histidyl-L-prolyl-L-seryl-L-lysyl-L-valyl-L-alpha-aspartyl-L-leucyl-L-prolyl-;(4S)-5-(((1S)-2-(((1S)-1-(((1S)-2-((2S)-2-(((1S)-2-(((1S)-5-Amino-1-(((1S)-1-(((1S)-1-(((1S)-1-((2S)-2-(((1S)-1-carboxy-4-guanidino-butyl)carbamoyl)pyrrolidine-1-carbonyl)-3-methyl-butyl)carbamoyl)-3-hydroxy-3-oxo-propyl)carbamoyl)-2-methyl-propyl)ca;L-ARGININE, L-LYSYL-L-.ALPHA.-GLUTAMYL-L-PHENYLALANYL-L-LEUCYL-L-HISTIDYL-L-PROLYL-L-SERYL-L-LYSYL-L-VALYL-L-.ALPHA.-ASPARTYL-L-LEUCYL-L-PROLYL-;CHEMBL4228250;GTPL12562;BDBM50459973;DB15366;DA-58010;TRPV6 Calcium Channel Inhibitor SOR-C13;Q27895873;H-Lys-Glu-Phe-Leu-His-Pro-Ser-Lys-Val-Asp-Leu-Pro-Arg-OH;
Chemical Name:(4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-4-(diaminomethylideneamino)butyl]carbamoyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-[[(2S)-2,6-diaminohexanoyl]amino]-5-oxopentanoic acid
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.